Delisting risk
Impact BioMedical
Commercializes health-and-wellness patents and Celios air-purification products.
$0.4437
After-hours close−0.01 (−1.16%)
At close$0.4489(+1.79%)
Something off on this page? Send us feedback.
Breakdown13F · Form 4
Institutions 3.45%Insiders —
Shares outstanding 107.82M · Float 107.32M · 99.5% free float
Institutions13F, as of Mar 31, 2026
19 holders · 3.72M shares · 7 new positions · 13 increased · 1 reduced · 10 closed
| Holder | Shares | % outstanding | Chg q/q | Filed |
|---|---|---|---|---|
| Geode Capital Management, LLC | 1.19M | 1.11% | +1.12M | May 15, 2026 |
| Vanguard Capital Management LLC | 708.2K | 0.66% | +708.2Knew | May 15, 2026 |
| State Street Corp | 607.9K | 0.56% | +596.1K | May 15, 2026 |
| Vanguard Fiduciary Trust Co | 585.2K | 0.54% | +585.2Knew | May 8, 2026 |
| BlackRock, Inc. | 259.9K | 0.24% | 0 | May 13, 2026 |
| Northern Trust Corp | 243.9K | 0.23% | +233.7K | May 14, 2026 |
| Two Sigma Investments, LP | 37.4K | 0.03% | −2.4K | May 15, 2026 |
| UBS Group AG | 32.4K | 0.03% | +30.2K | May 5, 2026 |
Beneficial owners13D/G · 5% or more, as filed
No 13D/G filer at 5% or more on record.
InsidersForm 4
Latest trades
Nothing filed in the last 12 months.
CongressHouse and Senate disclosures
Not reported.